Loopbaan van Charles Sang
Eerdere bekende functies van Charles Sang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01-04-2016 | 09-04-2020 |
| NANOSTRING TECHNOLOGIES, INC. | Corporate Officer/Principal | 01-11-2012 | 01-04-2016 |
| SEAGEN INC. | Verkoop & Marketing | 01-07-2010 | 01-11-2012 |
Opleiding van Charles Sang
| National-Louis University | Undergraduate Degree |
| New Mexico State University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| NANOSTRING TECHNOLOGIES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Beurs
- Insiders
- Charles Sang
- Ervaring